Scandinavian Tobacco Group (STG) AGM 2025 summary
Event summary combining transcript, slides, and related documents.
AGM 2025 summary
29 Nov, 2025Opening remarks and agenda
The meeting was convened in accordance with legal and statutory requirements, with English as the official language and Danish summaries provided.
The agenda included financial review, adoption of the annual report, profit appropriation, remuneration, board elections, auditor appointment, and board/shareholder proposals.
Financial performance review
Net sales reached DKK 9.2 billion, a record high, with EBITDA before special items at DKK 2.1 billion and net profit of DKK 940 million.
Free cash flow before acquisitions was DKK 931 million; adjusted earnings per share was DKK 13.7.
Sales growth was driven by the Mac Baren acquisition and growth enablers, despite margin pressure from investments and market challenges.
All three commercial divisions reported sales growth, with online and retail channels in North America showing double-digit growth.
Dividend announcements
Proposed dividend of DKK 8.5 per share, marking the ninth consecutive annual increase, totaling DKK 731 million.
Share buyback program of DKK 850 million completed, with total capital return close to DKK 1.5 billion in 2024.
Latest events from Scandinavian Tobacco Group
- Organic sales fell 8.8% in Q1 2025, prompting lower guidance amid US and FX headwinds.STG
Q1 202513 Mar 2026 - 2025 results declined, but Focus2030 and strong cash flow support a stable 2026 outlook.STG
Q4 20259 Mar 2026 - Focus2030 targets growth in cigars and nicotine pouches, efficiency, and flexible shareholder returns.STG
CMD 20253 Feb 2026 - Q2 2024 saw 6.3% sales growth, margin gains, and a strategic acquisition for future expansion.STG
Q2 202423 Jan 2026 - Q3 net sales up 7.1% on Mac Baren deal; margin and organic growth declined.STG
Q3 202414 Jan 2026 - Net sales up 5.4% to DKK 9.2bn, but profit down 20.5% amid margin pressure and investments.STG
Q4 202426 Dec 2025 - Q2 2025 saw flat sales, margin pressure, and guidance reaffirmed despite organic decline.STG
Q2 202523 Nov 2025 - Q3 2025 organic sales rose 0.3% with margin recovery and narrowed full-year guidance.STG
Q3 202512 Nov 2025